Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccination
暂无分享,去创建一个
P. Korošec | M. Rijavec | E. Škof | Marina Čakš | M. Ivanović | M. Ravnik | U. Janzic | Urška Bidovec‐Stojkovič | J. Debeljak | K. Mohorčič | Loredana Mrak | N. Dovnik | Urska Bidovec-Stojkovic